Reviewed,
UniProtKB/Swiss-Prot P08183 (MDR1_HUMAN)
Last modified
November 25, 2008.
Version 113.
History...
Clusters with 100%,
90%,
50% identity |
Documents (7) |
Third-party data |
Customize display | text xml rdf/xml gff fasta |
Names and origin
| Protein names | Recommended name: Multidrug resistance protein 1 EC=3.6.3.44 Alternative name(s): ATP-binding cassette sub-family B member 1 P-glycoprotein 1 CD_antigen=CD243 | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 1280 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is not processed. |
| Protein existence | Evidence at protein level. |
General annotation (Comments)
| Function | Energy-dependent efflux pump responsible for decreased drug accumulation in multidrug-resistant cells. |
| Catalytic activity | ATP + H(2)O + xenobiotic(In) = ADP + phosphate + xenobiotic(Out). |
| Subcellular location | |
| Tissue specificity | Expressed in liver, kidney, small intestine and brain. |
| Polymorphism | Genetic variation in ABCB1 may play a role in patients who do not respond to drug treatment. |
| Sequence similarities | Belongs to the ABC transporter family. Multidrug resistance exporter (TC 3.A.1.201) subfamily. [View classification] Contains 2 ABC transmembrane type-1 domains. Contains 2 ABC transporter domains. |
| Sequence caution | The sequence AAB69423.1 differs from that shown. Reason: Erroneous gene model prediction. |
Ontologies
Keywords | |
|---|---|
| Biological process | Transport |
| Cellular component | Membrane |
| Coding sequence diversity | Polymorphism |
| Domain | Repeat Transmembrane |
| Ligand | ATP-binding Nucleotide-binding |
| Molecular function | Hydrolase |
| PTM | Glycoprotein |
Gene Ontology (GO) | |
| Biological process | response to drug Traceable author statement. Source: ProtInc transportTraceable author statement. Source: ProtInc |
| Cellular component | cell surface Inferred from direct assay. Source: UniProtKB integral to membraneTraceable author statement. Source: ProtInc membrane fractionTraceable author statement. Source: ProtInc |
| Molecular function | ATP binding Traceable author statement. Source: ProtInc protein bindingInferred from physical interaction. Source: IntAct xenobiotic-transporting ATPase activityInferred from electronic annotation. Source: EC |
| Complete GO annotation... | |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 1280 | 1280 | Multidrug resistance protein 1 | PRO_0000093332 | |||||
Regions | |||||||||
| Topological domain | 1 – 51 | 51 | Cytoplasmic Potential | ||||||
| Transmembrane | 52 – 72 | 21 | Potential | ||||||
| Transmembrane | 120 – 140 | 21 | Potential | ||||||
| Transmembrane | 189 – 209 | 21 | Potential | ||||||
| Transmembrane | 216 – 236 | 21 | Potential | ||||||
| Transmembrane | 297 – 317 | 21 | Potential | ||||||
| Transmembrane | 326 – 346 | 21 | Potential | ||||||
| Topological domain | 347 – 710 | 364 | Cytoplasmic Potential | ||||||
| Transmembrane | 711 – 731 | 21 | Potential | ||||||
| Transmembrane | 757 – 777 | 21 | Potential | ||||||
| Transmembrane | 833 – 853 | 21 | Potential | ||||||
| Transmembrane | 854 – 874 | 21 | Potential | ||||||
| Transmembrane | 937 – 957 | 21 | Potential | ||||||
| Transmembrane | 974 – 994 | 21 | Potential | ||||||
| Topological domain | 995 – 1280 | 286 | Cytoplasmic Potential | ||||||
| Domain | 51 – 357 | 307 | ABC transmembrane type-1 1 | ||||||
| Domain | 392 – 628 | 237 | ABC transporter 1 | ||||||
| Domain | 711 – 1000 | 290 | ABC transmembrane type-1 2 | ||||||
| Domain | 1035 – 1273 | 239 | ABC transporter 2 | ||||||
| Nucleotide binding | 427 – 434 | 8 | ATP 1 By similarity | ||||||
| Nucleotide binding | 1070 – 1077 | 8 | ATP 2 By similarity | ||||||
Amino acid modifications | |||||||||
| Glycosylation | 91 | 1 | N-linked (GlcNAc...) Potential | ||||||
| Glycosylation | 94 | 1 | N-linked (GlcNAc...) Potential | ||||||
| Glycosylation | 99 | 1 | N-linked (GlcNAc...) Potential | ||||||
Natural variations | |||||||||
| Natural variant | 17 | 1 | F → L | VAR_022276 | |||||
| Natural variant | 21 | 1 | N → D: dbSNP rs1805053. | VAR_014704 | |||||
| Natural variant | 103 | 1 | F → L Rare polymorphism. | VAR_015001 | |||||
| Natural variant | 108 | 1 | E → K | VAR_018351 | |||||
| Natural variant | 185 | 1 | G → V in a colchicine-selected multidrug-resistant cell line; confers increased resistance to colchicine. | VAR_015002 | |||||
| Natural variant | 400 | 1 | S → N | VAR_015003 | |||||
| Natural variant | 566 | 1 | E → K | VAR_022277 | |||||
| Natural variant | 593 | 1 | R → C | VAR_022278 | |||||
| Natural variant | 836 | 1 | I → V | VAR_022279 | |||||
| Natural variant | 887 | 1 | K → N in a colorectal cancer sample; somatic mutation. | VAR_035737 | |||||
| Natural variant | 893 | 1 | A → S: dbSNP rs2032582. | VAR_013361 | |||||
| Natural variant | 893 | 1 | A → T: dbSNP rs2032582. | VAR_013362 | |||||
| Natural variant | 986 | 1 | M → V | VAR_018352 | |||||
| Natural variant | 999 | 1 | A → T | VAR_015004 | |||||
| Natural variant | 1051 | 1 | P → A | VAR_022280 | |||||
| Natural variant | 1107 | 1 | Q → P | VAR_015005 | |||||
| Natural variant | 1141 | 1 | S → T | VAR_022281 | |||||
| Natural variant | 1251 | 1 | V → I | VAR_018353 | |||||
Experimental info | |||||||||
| Sequence conflict | 23 | 1 | S → R in CAA41558. Ref.7 | ||||||
| Sequence conflict | 336 | 1 | Missing in AAB69423. Ref.3 | ||||||
| Sequence conflict | 412 | 1 | G → A Ref.3 | ||||||
| Sequence conflict | 438 | 1 | Q → S Ref.3 | ||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells." Chen C.-J., Chin J.E., Ueda K., Clark D.P., Pastan I., Gottesman M.M., Roninson I.B. Cell 47:381-389(1986) [PubMed: 2876781] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], VARIANT VAL-185. |
| [2] | "Genomic organization of the human multidrug resistance (MDR1) gene and origin of P-glycoproteins." Chen C.-J., Clark D.P., Ueda K., Pastan I., Gottesman M.M., Roninson I.B. J. Biol. Chem. 265:506-514(1990) [PubMed: 1967175] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]. |
| [3] | "Multidrug-resistant human sarcoma cells with a mutant P-glycoprotein, altered phenotype, and resistance to cyclosporins." Chen G., Duran G.E., Steger K.A., Lacayo N.J., Jaffrezou J.P., Dumontet C., Sikic B.I. J. Biol. Chem. 272:5974-5982(1997) [PubMed: 9038218] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], VARIANT VAL-185. |
| [4] | "NIEHS-SNPs, environmental genome project, NIEHS ES15478, Department of Genome Sciences, Seattle, WA (URL: http://egp.gs.washington.edu)." Livingston R.J., Rieder M.J., Rajkumar N., Downing T.K., Olson A.N., Nguyen C.P., Gildersleeve H., Cassidy C.M., Johnson E.J., Swanson J.E., McFarland I., Yool B., Park C., Nickerson D.A. Submitted (JAN-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA], VARIANTS LEU-17; ASP-21; ASN-400; LYS-566; CYS-593; VAL-836; ALA-1051; THR-1141 AND ILE-1251. |
| [5] | "The DNA sequence of human chromosome 7." Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H., Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R., Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E., Fewell G.A., Delehaunty K.D., Miner T.L. Wilson R.K.Nature 424:157-164(2003) [PubMed: 12853948] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [6] | "mdr1/P-glycoprotein gene segments analyzed from various human leukemic cell lines exhibiting different multidrug resistance profiles." Gekeler V., Weger S., Probst H. Biochem. Biophys. Res. Commun. 169:796-802(1990) [PubMed: 1972623] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 178-215 AND 800-856. |
| [7] | "P-glycoprotein gene (MDR1) cDNA from human adrenal: normal P-glycoprotein carries Gly185 with an altered pattern of multidrug resistance." Kioka N., Tsubota J., Kakehi Y., Komano T., Gottesman M.M., Pastan I., Ueda K. Biochem. Biophys. Res. Commun. 162:224-231(1989) [PubMed: 2568832] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 1-23, VARIANT SER-893. |
| [8] | "ABC drug transporters: hereditary polymorphisms and pharmacological impact in MDR1, MRP1 and MRP2." Kerb R., Hoffmeyer S., Brinkmann U. Pharmacogenomics 2:51-64(2001) [PubMed: 11258197] [Abstract] Cited for: REVIEW. |
| [9] | "An altered pattern of cross-resistance in multidrug-resistant human cells results from spontaneous mutations in the mdr1 (P-glycoprotein) gene." Choi K.H., Chen C.-J., Kriegler M., Roninson I.B. Cell 53:519-529(1988) [PubMed: 2897240] [Abstract] Cited for: VARIANT VAL-185. |
| [10] | "Genetic polymorphism in MDR-1: a tool for examining allelic expression in normal cells, unselected and drug-selected cell lines, and human tumors." Mickley L.A., Lee J.-S., Weng Z., Zhan Z., Alvarez M., Wilson W., Bates S.E., Fojo T. Blood 91:1749-1756(1998) [PubMed: 9473242] [Abstract] Cited for: VARIANTS SER-893 AND THR-999. |
| [11] | "A new polymorphism (N21D) in the exon 2 of the human MDR1 gene encoding the P-glycoprotein." Decleves X., Chevillard S., Charpentier C., Vielh P., Laplanche J.-L. Hum. Mutat. 15:486-486(2000) [PubMed: 10790226] [Abstract] Cited for: VARIANT ASP-21. |
| [12] | "Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo." Hoffmeyer S., Burk O., von Richter O., Arnold H.P., Brockmoeller J., Johne A., Cascorbi I., Gerloff T., Roots I., Eichelbaum M., Brinkmann U. Proc. Natl. Acad. Sci. U.S.A. 97:3473-3478(2000) [PubMed: 10716719] [Abstract] Cited for: VARIANTS ASP-21; LEU-103 AND ASN-400. |
| [13] | "Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter MDR1 gene in white subjects." Cascorbi I., Gerloff T., Johne A., Meisel C., Hoffmeyer S., Schwab M., Schaeffeler E., Eichelbaum M., Brinkmann U., Roots I. Clin. Pharmacol. Ther. 69:169-174(2001) [PubMed: 11240981] [Abstract] Cited for: VARIANTS ASP-21; ASN-400; SER-893; THR-893 AND PRO-1107. |
| [14] | "Polymorphism of MDR1 gene in healthy Japanese subjects: a novel SNP with an amino acid substitution (Glu108Lys)." Honda T., Dan Y., Koyabu N., Ieiri I., Otsubo K., Higuchi S., Ohtani H., Sawada J. Drug Metab. Pharmacokinet. 17:479-481(2002) [PubMed: 15618700] [Abstract] Cited for: VARIANT LYS-108. |
| [15] | "Twelve novel single nucleotide polymorphisms in ABCB1/MDR1 among Japanese patients with ventricular tachycardia who were administered amiodarone." Itoda M., Saito Y., Komamura K., Ueno K., Kamakura S., Ozawa S., Sawada J. Drug Metab. Pharmacokinet. 17:566-571(2002) [PubMed: 15618713] [Abstract] Cited for: VARIANT ILE-1251. |
| [16] | "Three hundred twenty-six genetic variations in genes encoding nine members of ATP-binding cassette, subfamily B (ABCB/MDR/TAP), in the Japanese population." Saito S., Iida A., Sekine A., Miura Y., Ogawa C., Kawauchi S., Higuchi S., Nakamura Y. J. Hum. Genet. 47:38-50(2002) [PubMed: 11829140] [Abstract] Cited for: VARIANTS SER-893 AND THR-893. |
| [17] | "The consensus coding sequences of human breast and colorectal cancers." Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D., Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V. Velculescu V.E.Science 314:268-274(2006) [PubMed: 16959974] [Abstract] Cited for: VARIANT [LARGE SCALE ANALYSIS] ASN-887. |
| + | Additional computationally mapped references. |
Web resources
| Atlas of Genetics and Cytogenetics in Oncology and Haematology |
| SHMPD The Singapore human mutation and polymorphism database |
| Wikipedia P-glycoprotein entry |

Clusters with